9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook complete response Also found in:Dictionary,Thesaurus,Financial,Acronyms,Encyclopedia. Abbreviation:CR Incancercare,theeradicationbytreatmentofallof areadilyidentifiabletumor.Acompleteresponsediffersfromacureinthatmicroscopicamoun...
MultiplemyelomaTen-yearsurvivorA 62-year-old woman with multiple myeloma, who has been in complete remission (CR) for 10 years, is reported. The patient was treated with conventional chemotherapy, including nitrosourea derivatives. Five patients with myeloma, including the present case, who have ...
The progressive improvement in the four clinical end points is readily appreciated with the transition from TT1 to TT2 to TT3. The plateau in the CR duration curve for TT1 from 10 years onward (bottom right panel, gold) is consistent with cure. ...
Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b. In a study of 29 patients who were receiving or had received interferon alpha 2b (IFN-alpha 2b) as maintenance therapy for multiple myeloma, antibodies were detected in 58% (17/29) of...
IgD multiple myeloma; complete remission; long-term remission Abstract: Long-term complete remission in IgD multiple myeloma (MM) is rare. This case report describes a patient with a stage IIIB IgD-MM, who was treated with conventional melphalan and prednisone chemotherapy. The monoclonal protei...
(1 − CurePrev) was <5% for most cancer types except for patients with breast cancer (8.3%) and patients with cancers of the lung (11.1%), kidney (13.2%), bladder (15.5%), vagina/vulva (16.7%), larynx (17.8%), oral cavity (21.2%), multiple myeloma (33.4%), and liver (44.9%...
In 1991, New York author and entrepreneur Walter Levine was diagnosed with multiple myeloma, mylanoma, and bladder cancers. After almost a year of conventional treatments, amounting to more than $440,000 in medical bills, his condition worsened. Walter's doctor told him that over 90% of his...
Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma. Cancer, 94 (4 suppl) (2002), pp. 1202-1209 Google Scholar 37 TM Behr, M Behe, MG Stabin, et al. High-linear energy transfer (LET) alpha versus low-LET...
The proportion of multiple myeloma patients in long-term complete response (LTCR-MM) for more than 6 years after autologous stem cell transplantation (ASCT) is small. To evaluate whether this LTCR is associated with a particular immune signature, peripheral blood samples from 13 LTCR-MM after ...
Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes J Clin Oncol 1987 5: 1822 1826 Article CAS PubMed Google Scholar Gahrton G, Tura S, Ljungman P et al. Allogeneic bone marrow transplantation in multiple myeloma New Engl J Med 1991 325: 1267 1273 Article CAS Pub...